Multiple myeloma is a type of blood cancer that originates in plasma cells, a kind of white blood cell responsible for producing antibodies that help the body fight infections. In multiple myeloma, abnormal plasma cells accumulate in the bone marrow, disrupting the production of normal blood cells and leading to various complications. While it is considered a rare form of cancer, it accounts for approximately 1% of all cancers and 13% of all blood cancers, predominantly affecting older adults.
Cancers We Treat
Causes and Risk Factors
The exact cause of multiple myeloma is not fully understood, but several risk factors have been identified, including:
- Age: The risk of developing multiple myeloma increases significantly with age, with most cases diagnosed in individuals over 65.
- Gender: Men are more likely to develop multiple myeloma than women.
- Family History: A family history of myeloma or other blood cancers can increase the risk.
- Certain Medical Conditions: Conditions such as monoclonal gammopathy of undetermined significance (MGUS) can increase the likelihood of developing multiple myeloma.
Symptoms
Symptoms of multiple myeloma can vary widely and may develop gradually. Common symptoms include persistent fatigue, bone pain (often in the back or ribs), frequent infections, and anemia. Patients may also experience kidney dysfunction, hypercalcemia (high levels of calcium in the blood), and unexplained weight loss. As the disease progresses, complications such as fractures or neurological issues may arise, emphasizing the importance of early diagnosis and treatment.
Treatment Options
Treatment for multiple myeloma typically involves a combination of therapies tailored to the individual patient. Common options include chemotherapy to reduce the number of myeloma cells, targeted therapy that focuses on specific characteristics of the cancer, and immunotherapy to enhance the immune response against the cancer. High-dose chemotherapy followed by a stem cell transplant may also be recommended for eligible patients to restore healthy bone marrow function. Additionally, supportive care is important to manage symptoms and complications, ensuring the best possible quality of life for individuals undergoing treatment.
Euromed has unique and effective treatment protocols that combine:
- Strengthening immune function through various IV’s and therapies
- Treating the cancer directly with very low dose insulin potentiated chemotherapy (IPT) and
- Changing your chemical terrain to make it inhospitable to cancer through diet and supplements as needed.
Prevention
While there is no known way to prevent multiple myeloma, certain lifestyle choices may help reduce the risk. Maintaining a healthy diet, engaging in regular physical activity, and avoiding tobacco can contribute to overall well-being. Individuals with risk factors, such as a history of MGUS, should discuss regular monitoring and potential preventive strategies with their healthcare provider.
Conclusion
Multiple myeloma is a complex and challenging blood cancer, but advancements in treatment options have significantly improved outcomes for many patients. Awareness of symptoms and risk factors, along with regular medical check-ups, can facilitate early diagnosis and effective management. With appropriate treatment, individuals diagnosed with multiple myeloma can lead fulfilling lives and effectively manage their condition.
FAQ
Common Questions
What is alternative or integrative cancer treatment?
At EuroMed Foundation, alternative or integrative cancer treatment is an overarching term we use to describe the many complementary therapies we employ to kill cancer cells and support your body’s ability to heal itself. Licensed integrative cancer medicine specialists oversee all of our treatments, which have been shown to benefit overall health and well-being while treating the malignancy.
What are my treatment options?
Our treatments target cancer cells with low-dose chemotherapy while strengthening your health and immune system. We offer the George Protocol, which involves a homeopathic immune modulator, and numerous other complementary therapies as part of a customized treatment plan that targets your precise condition. We believe combining many positive treatments creates the best results.
Is alternative or integrative cancer treatment safe?
Our alternative or integrative cancer therapies are much safer than traditional treatments such as full-dose chemotherapy and radiation because the body is exposed to much less toxicity. Licensed physicians who hold themselves to the highest medical and ethical standards perform all treatments. They are committed to improving the well-being and the life of every patient who visits EuroMed Foundation.
Is alternative or integrative treatment as effective as traditional treatment?
Many of our patients turn to us after months or years of unsuccessfully fighting cancer using traditional treatments. For many patients, alternative or integrative therapies provide effective treatments to fight off their disease.
Is alternative cancer treatment covered by insurance?
Whether your treatment is covered by your insurance provider depends on your selected therapy and your coverage plan. Our staff can help you navigate the sometimes complicated intricacies of your plan to determine whether you might qualify for coverage.
Are there alternative therapies I can follow at home?
Yes. We help patients make lifestyle changes, including nutrition and exercise, that boost the immune system. We also introduce ways to help patients relieve their minds. Many side effects of cancer – such as fatigue, nausea, sleep problems, stress, and pain – can be alleviated through changes in diet, nutritional supplements, basic relaxation techniques, or a combination of these. The EuroMed Foundation team considers our patients as family and we give them specific strategies to improve their health and overcome cancer.
Am I a Good Candidate for Alternative Cancer Treatment?
Most patients who contact us will respond well to our therapies. That includes many who have already undergone conventional chemotherapy, radiation therapy, and/or surgery. Those treatments typically suppress the function of your immune system, which needs to be strengthened and retrained for effective long-term success of alternative treatments.
In certain cases a patient’s cancer is too advanced or doesn’t respond to our therapy. In those situations we usually refer that patient to another cancer center for treatment that is better suited to them. Our doctors will evaluate your condition and find a treatment path that is customized for you.
DO, MD(H), Medical Director Emeritus
Frank George
He was the first osteopathic physician in the United States trained in Insulin Potentiation Therapy (IPT). He was also an accomplished chelating physician with the use of EDTA, DMPS, and DMSA for heavy metal toxicity and cardiovascular disorders. Dr. George’s legacy and protocols continue to live and thrive in our clinic.